01 11Kadcyla
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 1,435
2018 Revenue in Millions : 1,008
Growth (%) : 42
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 1,944
2019 Revenue in Millions : 1,552
Growth (%) : 25
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 2,133
2020 Revenue in Millions : 1,850
Growth (%) : 14
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 2,274
2021 Revenue in Millions : 2,133
Growth (%) : 7
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 2,281
2022 Revenue in Millions : 2,274
Growth (%) : -5
Main Therapeutic Indication : Oncology
Currency : USD
2024 Revenue in Millions : 2,201
2023 Revenue in Millions : 2,281
Growth (%) : -4
Main Therapeutic Indication : Oncology
Currency : USD
2014 Revenue in Millions : 129.10%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Oncology
Currency : USD
2015 Revenue in Millions : 541
2014 Revenue in Millions : 777
Growth (%) : 44%
Main Therapeutic Indication : Oncology
Currency : USD
2016 Revenue in Millions : 823
2015 Revenue in Millions : 761
Growth (%) : 8
Main Therapeutic Indication : Oncology
Currency : USD
2017 Revenue in Millions : 969
2016 Revenue in Millions : 881
Growth (%) : 10
